Regis Healthcare (ASX:REG) share price dives 8% on potential $40m underpayment

The company is hoping a quick remedy to its potential breach.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is having a woeful day on the ASX boards today. This comes after the aged care operator released a statement regarding potential employee underpayments.

At the time of writing, Regis shares are being heavily sold off as a result, down 8.10% to $1.93.

share price plummeting down

Image source: Getty Images

Regis flags employee underpayments

In its notice, Regis advised it has identified possible underpayments made to current and former employees under its enterprise agreements. These payments relate specifically to employee entitlements.

The company blamed the miscalculation on inaccurate entries on its payroll system which has affected a number of workers.

To correct the issue, Regis is working with external auditors to commence a review and determine the amount underpaid. It noted that the process requires an extensive analysis of complex enterprise agreements and historical employee entitlement and payroll data.

Based on preliminary estimates, Regis is expecting potential underpayments to be in the range of $30 million to $40 million. This is taking into consideration the past 6 years of both current and past employees.

Regis managing director and CEO, Dr Linda Mellors said:

While we are deeply disappointed this has occurred, our priority is to identify the amounts owed to our people and paying those amounts as soon as our review is complete. We are also upgrading our payroll system and improving internal processes to mitigate the risk of such issues recurring. Our Board is meeting regularly to monitor progress and ensure remediation occurs in a timely manner. I would like to offer my apologies to our people affected by this issue.

The impact to Regis' profit before income tax for FY21 is forecasted to be between $6 million and $7 million. The remaining amount is set to be recorded as a prior period restatement in accordance with Australian Accounting Standard AASB.

In addition, the company stated that it is upgrading its payroll system and improving internal processes in the meantime. Employee entitlement underpayments are projected to be minimal in the 2022 financial year.

About the Regis share price

Over the last 12 months, Regis shares have gained around 40% for shareholders. However, year-to-date remains relatively flat, up 3%.

On valuation grounds, Regis presides a market capitalisation of roughly $576 million, with approximately 300 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Three brightly coloured objects against a backdrop of blue, indication three winning ASX share prices
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre session on the ASX this Thursday.

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Deep Yellow, Develop Global, Resolute Mining, and Santos shares are pushing higher today

These shares are catching the eye on Thursday. But why?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »